{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1213.109","meta":{"versionId":"5","lastUpdated":"2023-12-03T01:08:00.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Meaningful Drug Interaction Alerts Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-12-03"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-12-03"}],"url":"https://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1213.109"}],"version":"20231203","name":"OralAnticoagulantIngredientsAndRiskOfGIBleeding","title":"Oral Anticoagulant Ingredients and Risk of GI Bleeding","status":"active","experimental":true,"date":"2023-12-03T01:08:00-05:00","publisher":"Meaningful Drug Interaction Alerts Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for oral anticoagulants at an ingredietn level and identified products containing those: warfarin, apixaban, edoxaban, dabigatran and rivaroxaban),(Data Element Scope: This value uses the corresponding RxCui for each ingredient of interest),(Inclusion Criteria: Includes concepts that describe oral anticoagulants),(Exclusion Criteria: Excludes concepts that describe branded and non-prescribable oral anticoagulants)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1037042","display":"dabigatran etexilate"},{"code":"1114195","display":"rivaroxaban"},{"code":"11289","display":"warfarin"},{"code":"1364430","display":"apixaban"},{"code":"1546356","display":"dabigatran"},{"code":"1599538","display":"edoxaban"}]}]},"expansion":{"identifier":"urn:uuid:ffd00b56-81a5-4a0e-a97a-568f7e93d6bb","timestamp":"2023-12-10T23:30:10-05:00","total":6,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1037042","display":"dabigatran etexilate"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1114195","display":"rivaroxaban"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"11289","display":"warfarin"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1364430","display":"apixaban"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1546356","display":"dabigatran"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1599538","display":"edoxaban"}]}}